XERS - CIK 0001867096
Xeris Biopharma Holdings, Inc. has filed 290 documents with the SEC between 2021 and 2026. The most frequent type is insider trade (129 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Major company event | 8-K | 2024-11-08 | 2024-11-08 |
| Insider trade | 4 | 2024-08-13 | 2024-08-12 |
| SEC correspondence | UPLOAD | 2024-08-13 | - |
| Insider trade | 4 | 2024-08-12 | 2024-08-09 |
| Insider trade | 4 | 2024-08-09 | 2022-01-29 |
| Insider trade | 4 | 2024-08-09 | 2022-01-29 |
| Insider trade | 4 | 2024-08-09 | 2022-01-29 |
| Employee stock plan | S-8 | 2024-08-08 | - |
| Quarterly report | 10-Q | 2024-08-08 | 2024-06-30 |
| Major company event | 8-K | 2024-08-08 | 2024-08-08 |
| Company correspondence | CORRESP | 2024-08-06 | - |
| Insider trade | 4 | 2024-08-02 | 2022-01-29 |
| Insider trade | 4 | 2024-08-02 | 2024-08-01 |
| New insider ownership | 3 | 2024-08-02 | 2024-08-01 |
| Major company event | 8-K | 2024-08-02 | 2024-08-01 |
| SEC correspondence | UPLOAD | 2024-07-22 | - |
| Major company event | 8-K | 2024-07-08 | 2024-07-07 |
| Company correspondence | CORRESP | 2024-06-21 | - |
| SEC correspondence | UPLOAD | 2024-06-12 | - |
| Insider trade | 4 | 2024-06-05 | 2024-06-05 |
| Insider trade | 4 | 2024-06-05 | 2024-06-05 |
| Insider trade | 4 | 2024-06-05 | 2024-06-05 |
| Insider trade | 4 | 2024-06-05 | 2024-06-05 |
| Insider trade | 4 | 2024-06-05 | 2024-06-05 |
| Insider trade | 4 | 2024-06-05 | 2024-06-05 |
| Insider trade | 4 | 2024-06-05 | 2024-06-05 |
| Insider trade | 4 | 2024-06-05 | 2024-06-05 |
| Major company event | 8-K | 2024-06-05 | 2024-06-05 |
| Insider trade | 4 | 2024-05-10 | 2024-05-10 |
| Quarterly report | 10-Q | 2024-05-09 | 2024-03-31 |
| Major company event | 8-K | 2024-05-09 | 2024-05-09 |
| Annual report to shareholders | ARS | 2024-04-23 | 2023-12-31 |
| Proxy materials | DEFA14A | 2024-04-23 | - |
| Proxy statement | DEF 14A | 2024-04-23 | 2024-06-05 |
| Insider trade | 4 | 2024-04-11 | 2024-03-15 |
| Insider trade | 4 | 2024-04-01 | 2024-03-15 |
| Insider trade | 4 | 2024-04-01 | 2024-03-15 |
| Insider trade | 4 | 2024-03-18 | 2024-03-18 |
| Insider trade | 4 | 2024-03-14 | 2024-03-14 |
| Employee stock plan | S-8 | 2024-03-06 | - |
| Annual report | 10-K | 2024-03-06 | 2023-12-31 |
| Major company event | 8-K | 2024-03-06 | 2024-03-05 |
| Passive ownership stake | SC 13G | 2024-02-13 | - |
| Passive ownership stake (update) | SC 13G/A | 2024-02-13 | - |
| Insider trade | 4 | 2024-01-31 | 2024-01-31 |
| Insider trade | 4 | 2024-01-31 | 2024-01-31 |
| Insider trade | 4 | 2024-01-31 | 2024-01-31 |
| Insider trade | 4 | 2024-01-31 | 2024-01-31 |
| Insider trade | 4 | 2024-01-31 | 2024-01-31 |
| Passive ownership stake | SC 13G | 2024-01-26 | - |